Analytical Data
-
Gene name
IGFL1
- Application
-
Alternative Names
IGFL1; UNQ644/PRO1274; Insulin growth factor-like family member 1
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UW32
-
Expression Region
25-110aa
-
Molecular Weight
16.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGFL1, or Insulin-like Growth Factor-Like Protein 1, is a key member of the insulin-like growth factor (IGF) family, which plays a critical role in growth and development. Research into IGFL1 has gained momentum due to its potential implications in various physiological and pathological processes, including cell proliferation, differentiation, and metabolic regulation. It has been observed that IGFL1 may exert its effects through interactions with IGF receptors, influencing cellular signaling pathways that are vital for normal biological functions. Additionally, abnormalities in IGFL1 expression have been associated with several diseases, including cancers and metabolic disorders, raising interest in its therapeutic potential. The recombinant production of IGFL1 protein allows for detailed studies of its structure-function relationships, enabling researchers to probe its mechanisms of action and delineate its role in health and disease. By understanding the biological functions and interactions of IGFL1, scientists aim to uncover novel strategies for therapeutic intervention and biomarker development, contributing to the broader field of growth factor research and its applications in regenerative medicine and oncology.
